DK0655926T3 - Ny sonde til tumordiagnose eller tumorterapi - Google Patents
Ny sonde til tumordiagnose eller tumorterapiInfo
- Publication number
- DK0655926T3 DK0655926T3 DK93917719T DK93917719T DK0655926T3 DK 0655926 T3 DK0655926 T3 DK 0655926T3 DK 93917719 T DK93917719 T DK 93917719T DK 93917719 T DK93917719 T DK 93917719T DK 0655926 T3 DK0655926 T3 DK 0655926T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- tumor
- diagnosis
- therapy
- new probe
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 4
- 238000003745 diagnosis Methods 0.000 title abstract 2
- 238000002560 therapeutic procedure Methods 0.000 title abstract 2
- 239000000523 sample Substances 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 230000000692 anti-sense effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000000032 diagnostic agent Substances 0.000 abstract 1
- 229940039227 diagnostic agent Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000014509 gene expression Effects 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1135—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against oncogenes or tumor suppressor genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
- C12N2310/3517—Marker; Tag
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- Rheumatology (AREA)
- Plant Pathology (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4225569A DE4225569C2 (de) | 1992-08-03 | 1992-08-03 | Verwendung einer Sonde zur Tumordiagnostik oder Tumortherapie |
| PCT/EP1993/002051 WO1994003196A1 (de) | 1992-08-03 | 1993-08-02 | Neue sonde zur tumordiagnostik oder tumortherapie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0655926T3 true DK0655926T3 (da) | 1998-09-21 |
Family
ID=6464707
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK93917719T DK0655926T3 (da) | 1992-08-03 | 1993-08-02 | Ny sonde til tumordiagnose eller tumorterapi |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5747250A (da) |
| EP (1) | EP0655926B1 (da) |
| JP (1) | JPH07509477A (da) |
| AT (1) | ATE162721T1 (da) |
| CA (1) | CA2141678A1 (da) |
| DE (2) | DE4225569C2 (da) |
| DK (1) | DK0655926T3 (da) |
| ES (1) | ES2114615T3 (da) |
| HK (1) | HK1002531A1 (da) |
| WO (1) | WO1994003196A1 (da) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6071697A (en) * | 1992-08-03 | 2000-06-06 | Max-Planck Gesellschaft Zur Forderung Der Wissenschaften E.V. | Method for testing the differentiation status in pancreatic cells of a mammal |
| DE19605105A1 (de) | 1996-02-12 | 1997-08-14 | Gsf Forschungszentrum Umwelt | Neue Sonde zur Früherkennung von epithelialen Dysplasien des mehrschichtigen Plattenepithels sowie zur Tumordiagnostik und Tumortherapie von Plattenepithelkarzinomen |
| EP1288311A3 (en) * | 1996-12-31 | 2004-09-29 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Method for testing small pharmaceutically active molecules in the activation of Pax4 and production of insulin producing beta-cells |
| DK0958357T3 (da) * | 1996-12-31 | 2006-02-20 | Max Planck Gesellschaft | Hidtil ukendt fremgangsmåde til testning af differentieringsstatussen i pancreasceller fra et pattedyr |
| GB9811598D0 (en) * | 1998-05-30 | 1998-07-29 | Imp College Innovations Ltd | Diagnosis and treatment of cancer |
| GB9903841D0 (en) * | 1999-02-20 | 1999-04-14 | Imp College Innovations Ltd | Diagnosis and treatment of cancer |
| WO2001046405A2 (en) * | 1999-12-22 | 2001-06-28 | Mcgill University | Modulation of pax-2 for controlled apoptosis or survival of cells |
| WO2001052789A2 (en) | 2000-01-20 | 2001-07-26 | The Brigham And Women's Hospital, Inc. | PAX8-PPARη NUCLEIC ACID MOLECULES AND POLYPEPTIDES AND USES THEREOF |
| CN1320634A (zh) * | 2000-04-27 | 2001-11-07 | 上海博德基因开发有限公司 | 一种新的多肽——人含配对盒结构域的蛋白20和编码这种多肽的多核苷酸 |
| CN1320616A (zh) * | 2000-04-27 | 2001-11-07 | 上海博德基因开发有限公司 | 一种新的多肽——人Pax蛋白17和编码这种多肽的多核苷酸 |
| CN1321681A (zh) * | 2000-04-29 | 2001-11-14 | 上海博德基因开发有限公司 | 一种新的多肽——人Pax蛋白11.3和编码这种多肽的多核苷酸 |
| US7601696B1 (en) | 2003-08-22 | 2009-10-13 | University Of South Florida | Oct-1 as an oncoprotein and use of nucleic acid inhibitors of Oct-1 for cancer treatment |
| US8080534B2 (en) | 2005-10-14 | 2011-12-20 | Phigenix, Inc | Targeting PAX2 for the treatment of breast cancer |
| KR101088885B1 (ko) * | 2008-12-23 | 2011-12-07 | 연세대학교 산학협력단 | 바이오프로브, 그 제조방법, 상기를 사용한 분석 장치 및 분석 방법 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05504476A (ja) * | 1989-12-27 | 1993-07-15 | アメリカ合衆国 | ヒト胃癌検出用診断プローブ |
| KR100242278B1 (ko) * | 1991-02-08 | 2000-02-01 | 장-끌로드 비에이으포스 | 인체 임파구 수용체의 알파사슬의 가변성영역을 코딩하는 뉴클레오티드 서열 및 그의 응용 |
-
1992
- 1992-08-03 DE DE4225569A patent/DE4225569C2/de not_active Expired - Fee Related
-
1993
- 1993-08-02 JP JP6505003A patent/JPH07509477A/ja active Pending
- 1993-08-02 DE DE59308082T patent/DE59308082D1/de not_active Expired - Fee Related
- 1993-08-02 ES ES93917719T patent/ES2114615T3/es not_active Expired - Lifetime
- 1993-08-02 CA CA002141678A patent/CA2141678A1/en not_active Abandoned
- 1993-08-02 DK DK93917719T patent/DK0655926T3/da active
- 1993-08-02 AT AT93917719T patent/ATE162721T1/de not_active IP Right Cessation
- 1993-08-02 WO PCT/EP1993/002051 patent/WO1994003196A1/de active IP Right Grant
- 1993-08-02 EP EP93917719A patent/EP0655926B1/de not_active Expired - Lifetime
- 1993-08-02 US US08/381,841 patent/US5747250A/en not_active Expired - Lifetime
-
1998
- 1998-02-25 HK HK98101460A patent/HK1002531A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE59308082D1 (de) | 1998-03-05 |
| DE4225569C2 (de) | 1996-04-25 |
| EP0655926B1 (de) | 1998-01-28 |
| ATE162721T1 (de) | 1998-02-15 |
| EP0655926A1 (de) | 1995-06-07 |
| ES2114615T3 (es) | 1998-06-01 |
| US5747250A (en) | 1998-05-05 |
| WO1994003196A1 (de) | 1994-02-17 |
| JPH07509477A (ja) | 1995-10-19 |
| HK1002531A1 (en) | 1998-08-28 |
| DE4225569A1 (de) | 1994-02-10 |
| CA2141678A1 (en) | 1994-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0655926T3 (da) | Ny sonde til tumordiagnose eller tumorterapi | |
| Hautmann et al. | A transforming growth factor β (TGFβ) control element drives TGFβ-induced stimulation of smooth muscle α-actin gene expression in concert with two CArG elements | |
| Mason et al. | Corticospinal neurons up‐regulate a range of growth‐associated genes following intracortical, but not spinal, axotomy | |
| BR9914643A (pt) | Vetores adeno-associados para expressão dofator viii por células alvo | |
| DE69433626D1 (de) | N-2 substituierte purine | |
| Lee et al. | Recombinant adenoviruses expressing dominant negative insulin-like growth factor-I receptor demonstrate antitumor effects on lung cancer | |
| DE69329240D1 (de) | 17-ether und thioether von 4-aza-steroiden | |
| NO954466D0 (no) | Adenovirale vektorer av animalsk opprinnelse samt deres anvendelse i genterapi | |
| DE69634412D1 (de) | Regulierte gene und ihre verwendungen | |
| EP1410804A4 (en) | CANCER VACCINE WITH CANCER ANTIGENS BASED ON TUMOR SUPPRESSOR GEN WT1 PRODUCT AND CATIONIC LIPOSOME | |
| DK1011723T3 (da) | 88KDA tumorgen vækstfaktor og antagonister | |
| ATE478686T1 (de) | Medikamente für massive tumore, welche inhibitoren der expression des wilms' tumorgens enthalten | |
| ATE188257T1 (de) | Benutzung von reagenzien abgeleitet vom menschlichen metastase unterdrückungs gen kai1 in diagnostischen und gen-terapeutischen verfahren | |
| BR9813917A (pt) | Vetores de expressão induzìveis hipertérmicospara terapia de genetica e métodos de uso dos mesmos | |
| WO2001044282A3 (en) | Bcl-g polypeptides, encoding nucleic acids and methods of use | |
| NZ504445A (en) | Nucleic acid sequences of genes of the high mobility group proteins and their use in treating tumours, vascular disorders and as a contraceptive | |
| ATE297464T1 (de) | Pharmazeutische zusammensetzungen zur therapie der herzinsuffizienz | |
| ATE204021T1 (de) | Klonierung, expression und charakterisierung einer neuen form der phosphatidylinositol-3- kinase | |
| HUP0201868A2 (en) | Antisense therapy for hormone-regulated tumors | |
| ATE314481T1 (de) | Promotor des transaldolase-genes von k.lactis und dessen verwendung | |
| DE69332375D1 (de) | Hundecoronavirus s gen und verwendung davon | |
| BR9306663A (pt) | Regiões antigênicas de complexos de partículas liberadas por tumores (TLP) e anticorpos contra os mesmos | |
| Batsakis et al. | Iatrogenic aberrations of serum enzyme activity | |
| US6844326B2 (en) | Treatment of alopecia | |
| ITMI20030860A1 (it) | Metodo per l'inibizione selettiva del gene n-myc |